SCHEMBL874713

SCHEMBL874713

N#Cc1ccc(C(=O)N(O)c2ccccc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.61
MEN1 O00255 1/20 0.61
NPC1 O15118 1/20 0.61
KDM4E B2RXH2 2/20 0.57
HPGD P15428 1/20 0.57
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
ALDH1A1 P00352 2/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TSHR P16473 1/20 0.43
GSK3B P49841 2/20 0.43
NSD2 O96028 2/20 0.43
NSD3 Q9BZ95 1/20 0.43
SNCA P37840 1/20 0.42
PKM P14618 1/20 0.42
ATM Q13315 1/20 0.42
TAS2R14 Q9NYV8 1/20 0.42
PGR P06401 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12103675 0.93 KMT2A (0.54) KMT2AMEN1NPC1KDM4EHPGD
SCHEMBL873994 0.85 HPGD (0.72) KMT2AMEN1NPC1KDM4EHPGD
SCHEMBL2112731 0.84 KMT2A (0.63) KMT2AMEN1NPC1KDM4ECA1
SCHEMBL11682285 0.83 KDM4E (0.65) KMT2AKDM4EHPGDCA1CA2
SCHEMBL30100512 0.83 KMT2A (0.61) KMT2AMEN1NPC1KDM4ECA1
SCHEMBL29273240 0.81 KMT2A (0.62) KMT2AMEN1NPC1KDM4EHPGD
SCHEMBL133668 0.81 KDM4E (0.67) KMT2AKDM4EHPGDCA1CA2
SCHEMBL23511690 0.80 HPGD (0.66) KMT2AMEN1NPC1KDM4EHPGD
SCHEMBL31393776 0.79 KMT2A (0.57) KMT2AMEN1NPC1KDM4ECA1
SCHEMBL27534541 0.79 KMT2A (0.47) KMT2AMEN1NPC1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4727818-B2 2011-07-20 JP claimed
US-6592867-B2 Capable of killing or inhibiting microbial cells or micro-organisms in laundry, on hard surfaces, in water systems, on skin, on teeth or on mucous membranes NOVOZYMES A/S (DK) 2003-07-15 US claimed
EP-1128730-B1 ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE NOVOZYMES AS (DK) 2003-05-02 EP claimed
JP-2002529380-A 2002-09-10 JP claimed
US-20020094331-A1 ANTIMICROBIAL COMPOSITION CONTAINING AN OXIDOREDUCTASE AND AN ENHANCER OF THER N-HYDROXYANILIDE-TYPE NOVOZYMES A/S (DK) 2002-07-18 US claimed
EP-1128730-A1 ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE Novozymes A/S (DK) 2001-09-05 EP claimed
WO-2000027204-A1 ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE NOVOZYMES A/S (DK) 2000-05-18 WO claimed
WO-2025242789-A1 METHOD FOR PRODUCING REINFORCED TEXTILE FIBER COMPOSITIONS LIGAMORE APS (DK) 2025-11-27 WO disclosed
EP-3444337-B1 METHOD OF CLEANING PROCTER & GAMBLE (US) 2024-12-18 EP disclosed
EP-3444336-B1 CLEANING AGENT PROCTER & GAMBLE (US) 2024-05-08 EP disclosed
US-20210147765-A9 CLEANING KIT THE PROCTER AND GAMBLE COMPANY 2021-05-20 US disclosed
US-20210071117-A9 CLEANING AGENT THE PROCTER AND GAMBLE COMPANY 2021-03-11 US disclosed
US-20200063073-A1 METHOD OF CLEANING THE PROCTER AND GAMBLE COMPANY 2020-02-27 US disclosed
WO-2001074980-A2 ENZYME TABLETS FOR CLEANING IMPROVEMENT NOVOZYMES A/S (DK) 2001-10-11 WO disclosed
EP-1128730-A1 ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE Novozymes A/S (DK) 2001-09-05 EP disclosed
WO-2001048304-A1 PROCESS FOR REMOVAL OF EXCESS DISPERSE DYE FROM PRINTED OR DYED TEXTILE MATERIAL NOVOZYMES A/S (DK) 2001-07-05 WO disclosed
WO-2001023513-A1 PARTICLES FOR LIQUID COMPOSITIONS NOVOZYMES A/S (DK) 2001-04-05 WO disclosed
WO-2001010195-A1 REDUCTION OF MALODOUR IN SOILED ANIMAL LITTER NOVOZYMES A/S (DK) 2001-02-15 WO disclosed
WO-2000068324-A2 ENZYMATIC PRESERVATION OF WATER BASED PAINTS NOVOZYMES A/S (DK) 2000-11-16 WO disclosed
WO-2000027204-A1 ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE NOVOZYMES A/S (DK) 2000-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094331-A1 ANTIMICROBIAL COMPOSITION CONTAINING AN OXIDOREDUCTASE AND AN ENHANCER OF THER N-HYDROXYANILIDE-TYPE LPO, MPO, LCT KMT2A 1201/4885MEN1 4497/4885NPC1 4238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.